Zuleika Aponte-Torres

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Respiratory Syncytial Virus

Angiotensin Converting Enzyme

Top Venues

Infectious diseases and therapy

Cell & bioscience

This page only lists publications with an associated author ORCID identifier.

Publications

Charles Nuttens, Juliette Moyersoen, Daniel Curcio, Zuleika Aponte-Torres, Marc Baay, Hilde Vroling, Bradford D Gessner, Elizabeth Begier
Differences Between RSV A and RSV B Subgroups and Implications for Pharmaceutical Preventive Measures. Infectious diseases and therapy 13 (8) (2024)
Charles Nuttens, Juliette Moyersoen, Daniel Curcio, Zuleika Aponte-Torres, Marc Baay, Hilde Vroling, Bradford D Gessner, Elizabeth Begier
Differences Between RSV A and RSV B Subgroups and Implications for Pharmaceutical Preventive Measures. Infectious diseases and therapy 13 (8) (2024)
Charles Nuttens, Juliette Moyersoen, Daniel Curcio, Zuleika Aponte-Torres, Marc Baay, Hilde Vroling, Bradford D Gessner, Elizabeth Begier
Differences Between RSV A and RSV B Subgroups and Implications for Pharmaceutical Preventive Measures. Infectious diseases and therapy (2024)
Charles Nuttens, Juliette Moyersoen, Daniel Curcio, Zuleika Aponte-Torres, Marc Baay, Hilde Vroling, Bradford D Gessner, Elizabeth Begier
Differences Between RSV A and RSV B Subgroups and Implications for Pharmaceutical Preventive Measures. Infectious diseases and therapy 13 (8) (2024)
Miriam Marlene Medina Enríquez, Sandra Lopez-León, José Alberto Carlos-Escalante, Zuleika Aponte-Torres, Angelica Cuapio, Talia Wegman-Ostrosky
ACE2: the molecular doorway to SARS-CoV-2. Cell & bioscience 10 (1) (2020)